Inventor · disambiguated record
Ming-Hong Xie
Also filed as: XIE MING · XIE MING-HONG
8 granted patents·10 pending applications·123 citations·filing 2001–2023
87Inventor score
Top patents by PatentIndex Score
18 records- 0195US10112997B2Tight-binding agents and uses thereofONCOMED PHARM INC·Filed 2016·Granted Oct 30, 2018·24 cites·17 claims
- 0294US6551799B2Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disordersGENENTECH INC·Filed 2001·Granted Apr 22, 2003·72 cites·6 claims
- 0388US9168300B2MET-binding agents and uses thereofONCOMED PHARM INC·Filed 2014·Granted Oct 27, 2015·6 cites·21 claims
- 0487US10544219B2TIGIT-binding agents and uses thereofONCOMED PHARM INC·Filed 2018·Granted Jan 28, 2020·5 cites·22 claims
- 0583US8178082B2Methods for up-regulating PAP1 in animals suffering from pancreatic disordersGURNEY AUSTIN L·Filed 2010·Granted May 15, 2012·5 cites·15 claims
- 0681US7226591B2Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disordersGENENTECH INC·Filed 2002·Granted Jun 5, 2007·10 cites·8 claims
- 0775US7445905B2Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disordersGENENTECH INC·Filed 2007·Granted Nov 4, 2008·1 cites·6 claims
- 0867US2022340653A1Methods for treatment of cancer comprising tigit-binding agentsMEREO BIOPHARMA 5 INC·Filed 2021·Application pending·0 cites
- 0965US2009130107A1Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disordersGURNEY AUSTIN L·Filed 2008·Application pending·0 cites
- 1061US2009093057A1Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disordersGENENTECH INC·Filed 2007·Application pending·0 cites
- 1161US2025339528A1Selection of optimal cell donors and methods and compositions for enhanced expansion and cytotoxicity of donor cellsNKARTA INC·Filed 2022·Application pending·0 cites
- 1259US2023390392A1Multiplex gene edited cells for cd70-directed cancer immunotherapyNKARTA INC·Filed 2023·Application pending·0 cites
- 1353US2017044268A1Immunotherapy with Binding AgentsONCOMED PHARM INC·Filed 2014·Application pending·0 cites
- 1452US9273334B2Methods of producing protoporphyrin IX and bacterial mutants thereforUNIV OKLAHOMA·Filed 2014·Granted Mar 1, 2016·0 cites·11 claims
- 1548US2016319034A1Met-binding agents and uses thereofONCOMED PHARM INC·Filed 2014·Application pending·0 cites
- 1648US2016137744A1Met-binding agents and uses thereofONCOMED PHARM INC·Filed 2015·Application pending·0 cites
- 1741US2018346571A1Pd-l1-binding agents and uses thereofONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 1838US2017267758A1Immunotherapy with binding agentsONCOMED PHARM INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ming-Hong Xie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →